Navigating the Regulatory Landscape for Topical Generics: Outsourcing-Pharma
July 29, 2021
The development and manufacture of topical generic products poses various challenges for pharma companies and their CDMOs, particularly when it comes to adhering to global regulations.
In this article with Outsourcing Pharma, Lynn Allen, Vice President of Business Development at MedPharm, discusses the evolution of the topical generics market and the key regulatory requirements pharma companies must comply with.
Read the full article here.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm specializes in reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through its unique, cost-effective, and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognized for their scientific rigor by regulators and investors. MedPharm has fully established Centers of Excellence in the USA and the UK.